Sign In
Buy RMTI
$7.19
+0.0900 (+1.27%)
At Close: Jul 31, 2026
Rockwell Medical Advances Quality and Regulatory Leadership
06:00am, Wednesday, 22'nd Jul 2026
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Brian Cox joins Rockwell Medical as VP, Quality and Regulatory Compliance, bringing more than 20 years' healthcare experience to the Com
Rockwell Medical Regains Compliance with Nasdaq Listing Requirements
06:00am, Monday, 20'th Jul 2026
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical received notice from Nasdaq that it regained compliance with the minimum bid price requirement under Nasdaq Listing Rul
Rockwell Medical to Release Second Quarter 2026 Results on Thursday, August 13, 2026
06:00am, Thursday, 16'th Jul 2026
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the second quarter ended June 30, 2026 on Thursday, August 13, 2026.
Rockwell Medical Announces 1-for-10 Reverse Stock Split
06:00am, Monday, 29'th Jun 2026
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical's Board of Directors has authorized a 1-for-10 reverse split of the Company's issued and outstanding common stock.
Rockwell Medical Renews Product Purchase Agreement with aQua Dialysis
06:00am, Wednesday, 20'th May 2026
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will supply aQua Dialysis with liquid and dry, acid and bicarbonate hemodialysis concentrates and other essential dialy
Rockwell Medical Signs New 3-Year Product Purchase Agreement with Heritage Dialysis
07:00am, Thursday, 14'th May 2026
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodia
Rockwell Medical Signs New 3-Year Product Purchase Agreement with Heritage Dialysis
06:00am, Thursday, 14'th May 2026
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will supply Heritage Dialysis with a portfolio of hemodialysis products including PureCart, RenalPure, SteriLyte and ot
Rockwell Medical, Inc. (RMTI) Q1 2026 Earnings Call Transcript
09:11pm, Thursday, 07'th May 2026
Rockwell Medical, Inc. (RMTI) Q1 2026 Earnings Call Transcript
Rockwell Medical (RMTI) Reports Q1 Loss, Misses Revenue Estimates
08:10am, Thursday, 07'th May 2026
Rockwell Medical (RMTI) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.04 per share a year ago.
Rockwell Medical Announces First Quarter 2026 Results and Additional 2026 Guidance with Focus on Profitability
06:00am, Thursday, 07'th May 2026
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical 2026 Guidance is centered around strengthening revenue, expanding gross margin, and generating positive Adjusted EBITDA
Rockwell Medical to Release First Quarter 2026 Results on Thursday, May 7, 2026
06:00am, Thursday, 09'th Apr 2026
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the first quarter ended March 31, 2026 on Thursday, May 7, 2026.
Should Value Investors Buy Rockwell Medical (RMTI) Stock?
10:41am, Friday, 27'th Mar 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Fast-paced Momentum Stock Rockwell Medical (RMTI) Is Still Trading at a Bargain
09:56am, Friday, 27'th Mar 2026
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Rockwell Medical (RMTI) could be a great choice. It is one of the several stocks tha
Rockwell Medical, Inc. (RMTI) Q4 2025 Earnings Call Transcript
10:45am, Thursday, 26'th Mar 2026
Rockwell Medical, Inc. (RMTI) Q4 2025 Earnings Call Transcript
Rockwell Medical (RMTI) Reports Q4 Loss, Misses Revenue Estimates
08:06am, Thursday, 26'th Mar 2026
Rockwell Medical (RMTI) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of $0.04. This compares to a loss of $0.02 per share a year ago.
